Company / Current Liabilities per Share
GeneDx Holdings Corp. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$3.89
FY2025
5-year range
$2.11 / $816806.45
FY2021-FY2025
Trend
+84.2%
vs FY2024
Sector context
#98 of 163
Health Care
What the data says
At $3.89, GeneDx Holdings Corp.'s current liabilities per share ranks #66 of 163 in the Health Care sector. Current Liabilities per Share returned to growth in FY2025 after 3 years of decline, reaching $3.89.
Based on SEC 10-K filings.
3.89 in FY2025 with a 5-year CAGR of -80.6%.
Improved from $5.00 to $3.89 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -94.8%
- 5-Year CAGR
- -80.6%
- 10-Year CAGR
- -
Sector benchmark
#66 of 163 in Health CareTop 40% of 163This company $3.89 Sector average $28.65
▼
-86.4% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 84.2% year-over-year.
- Ranks #98 out of 163 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.89 | +84.2% |
| FY2024 | $2.11 | -57.8% |
| FY2023 | $5.00 | -100.0% |
| FY2022 | $28122.59 | -96.6% |
| FY2021 | $816806.45 | +5606.6% |
| FY2020 | $14313.39 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026